Loading...
Keywords
Last Name
Institution

Rangaraj Selvarangan

Concepts (481)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Influenza, Human
18
2022
34
7.940
Why?
Parechovirus
14
2021
17
7.010
Why?
Enterovirus Infections
16
2022
28
6.860
Why?
Picornaviridae Infections
13
2021
18
6.680
Why?
Respiratory Tract Infections
16
2022
56
6.150
Why?
Molecular Diagnostic Techniques
13
2021
36
5.970
Why?
Influenza A virus
10
2020
17
5.790
Why?
Infant
78
2022
1371
5.380
Why?
Humans
135
2022
5964
5.280
Why?
Influenza B virus
11
2022
18
5.100
Why?
Respiratory Syncytial Virus Infections
10
2022
37
5.020
Why?
Child
82
2022
2796
4.480
Why?
Child, Preschool
69
2022
1442
4.370
Why?
Nucleic Acid Amplification Techniques
6
2020
13
4.080
Why?
Respiratory Syncytial Virus, Human
6
2022
18
4.020
Why?
Enterovirus D, Human
11
2022
20
3.760
Why?
Enterovirus
6
2021
8
3.670
Why?
Sensitivity and Specificity
28
2021
142
3.380
Why?
Anti-Bacterial Agents
17
2021
232
3.240
Why?
Gastroenteritis
13
2021
21
3.210
Why?
Female
71
2021
3320
3.110
Why?
Male
66
2021
3237
3.030
Why?
Disease Outbreaks
10
2022
23
2.870
Why?
Adolescent
45
2022
1931
2.740
Why?
Central Nervous System Infections
3
2021
5
2.670
Why?
United States
40
2022
621
2.660
Why?
Diagnostic Tests, Routine
5
2019
18
2.600
Why?
Real-Time Polymerase Chain Reaction
8
2020
33
2.570
Why?
Infant, Newborn
33
2021
877
2.570
Why?
Nasopharynx
10
2021
23
2.300
Why?
Feces
15
2021
33
2.210
Why?
Antibodies, Viral
9
2022
35
2.190
Why?
Bacteremia
5
2021
26
2.130
Why?
Streptococcal Infections
4
2020
20
2.100
Why?
Reverse Transcriptase Polymerase Chain Reaction
10
2020
87
1.980
Why?
Prospective Studies
19
2021
460
1.930
Why?
Reagent Kits, Diagnostic
9
2018
12
1.900
Why?
Hospitalization
16
2022
170
1.860
Why?
Virology
5
2015
5
1.740
Why?
Urinary Tract Infections
3
2021
22
1.700
Why?
Rotavirus Vaccines
7
2019
10
1.650
Why?
Young Adult
18
2021
582
1.640
Why?
Polymerase Chain Reaction
7
2019
98
1.580
Why?
Bacteriological Techniques
5
2021
7
1.560
Why?
DNA, Viral
4
2020
13
1.540
Why?
Point-of-Care Testing
2
2020
7
1.540
Why?
Adult
22
2021
1082
1.530
Why?
Sepsis
4
2018
24
1.510
Why?
Rotavirus Infections
9
2021
11
1.500
Why?
Middle Aged
16
2021
551
1.450
Why?
Mycoplasma pneumoniae
5
2020
12
1.440
Why?
Pneumonia, Mycoplasma
5
2020
13
1.440
Why?
Aged
13
2021
302
1.420
Why?
Clostridium Infections
3
2020
7
1.390
Why?
Aged, 80 and over
10
2021
115
1.370
Why?
Emergency Service, Hospital
6
2022
120
1.350
Why?
Retrospective Studies
18
2022
1166
1.340
Why?
Specimen Handling
5
2021
17
1.320
Why?
Staphylococcal Infections
4
2016
23
1.310
Why?
Staphylococcus aureus
3
2016
19
1.290
Why?
Norovirus
4
2021
5
1.260
Why?
Respiratory System
3
2015
5
1.230
Why?
Cerebrospinal Fluid
4
2020
8
1.220
Why?
Immunoassay
4
2015
10
1.190
Why?
Hematopoietic Stem Cell Transplantation
3
2020
44
1.170
Why?
Point-of-Care Systems
3
2020
14
1.170
Why?
Genotype
16
2021
298
1.150
Why?
Influenza Vaccines
5
2022
14
1.120
Why?
Bodily Secretions
2
2015
3
1.120
Why?
Caliciviridae Infections
3
2021
4
1.090
Why?
Antibodies, Neutralizing
4
2022
29
1.070
Why?
Streptococcus pyogenes
3
2020
13
1.070
Why?
Drug Resistance, Multiple, Bacterial
3
2021
11
1.060
Why?
Enterobacteriaceae
2
2021
5
1.060
Why?
Missouri
8
2022
83
1.060
Why?
Rhinovirus
2
2020
6
1.010
Why?
Vancomycin Resistance
2
2014
4
1.010
Why?
Escherichia coli
11
2017
33
1.000
Why?
Virus Diseases
2
2020
11
0.990
Why?
Inpatients
3
2020
49
0.970
Why?
Automation, Laboratory
2
2019
3
0.960
Why?
Coinfection
1
2022
5
0.960
Why?
Rotavirus
6
2021
7
0.960
Why?
Population Surveillance
6
2021
12
0.950
Why?
Time Factors
9
2020
269
0.940
Why?
Pharyngitis
2
2020
13
0.920
Why?
Multiplex Polymerase Chain Reaction
2
2018
6
0.920
Why?
Cephalosporins
2
2021
15
0.910
Why?
Itraconazole
2
2020
2
0.910
Why?
Triazoles
2
2020
4
0.910
Why?
Influenza A Virus, H1N1 Subtype
4
2022
7
0.910
Why?
Clinical Laboratory Techniques
5
2021
9
0.890
Why?
Neurodevelopmental Disorders
1
2021
12
0.880
Why?
Microbial Sensitivity Tests
12
2021
34
0.880
Why?
Mass Screening
2
2019
40
0.880
Why?
Bacterial Infections
1
2021
29
0.870
Why?
Phlebotomy
2
2011
2
0.860
Why?
Equipment Contamination
2
2011
6
0.850
Why?
Antiviral Agents
4
2021
23
0.850
Why?
Prevalence
11
2021
136
0.850
Why?
Enterocolitis, Pseudomembranous
1
2020
4
0.840
Why?
Asymptomatic Infections
1
2020
4
0.830
Why?
RNA Viruses
1
2019
3
0.810
Why?
Urinalysis
1
2019
6
0.790
Why?
Phylogeny
9
2021
18
0.790
Why?
Central Nervous System Viral Diseases
1
2019
3
0.780
Why?
Communicable Diseases, Emerging
1
2019
3
0.770
Why?
Antigens, Viral
3
2015
6
0.770
Why?
Peritonitis
2
2021
53
0.760
Why?
Drug Utilization
1
2018
14
0.740
Why?
Molecular Typing
1
2018
2
0.740
Why?
Respiratory Syncytial Viruses
2
2015
14
0.730
Why?
Bordetella Infections
2
2014
2
0.690
Why?
Bordetella parapertussis
2
2014
2
0.690
Why?
Peritoneal Dialysis
2
2021
148
0.690
Why?
Viral Vaccines
2
2022
8
0.680
Why?
Severity of Illness Index
6
2021
145
0.670
Why?
Escherichia coli Infections
7
2017
18
0.670
Why?
Carrier State
2
2018
5
0.660
Why?
Adhesins, Escherichia coli
9
2017
9
0.650
Why?
Methicillin-Resistant Staphylococcus aureus
5
2016
16
0.630
Why?
Fever
4
2021
26
0.620
Why?
Venous Thromboembolism
1
2015
10
0.600
Why?
Drug Resistance, Bacterial
5
2020
15
0.600
Why?
Sequence Analysis, DNA
7
2019
102
0.600
Why?
Herpes Simplex
2
2020
8
0.590
Why?
RNA, Viral
3
2015
18
0.580
Why?
Pharynx
3
2020
7
0.580
Why?
Mycoplasma
1
2015
2
0.580
Why?
Mycoplasma Infections
1
2015
2
0.580
Why?
Antigens, Bacterial
3
2011
9
0.570
Why?
Kansas
3
2022
45
0.560
Why?
Bordetella pertussis
1
2014
1
0.560
Why?
Spike Glycoprotein, Coronavirus
4
2022
19
0.560
Why?
Chromatography, Affinity
1
2014
3
0.560
Why?
Macrolides
5
2020
7
0.540
Why?
Blood Specimen Collection
2
2011
4
0.540
Why?
Case-Control Studies
8
2022
129
0.540
Why?
Seasons
6
2022
16
0.540
Why?
Vaccination
7
2022
42
0.530
Why?
Adenovirus Infections, Human
2
2011
3
0.530
Why?
Vancomycin
1
2014
17
0.530
Why?
Virus Cultivation
4
2015
4
0.530
Why?
Animals
12
2022
884
0.520
Why?
Candida
2
2003
3
0.520
Why?
Genetic Variation
3
2022
144
0.490
Why?
Pandemics
3
2022
56
0.490
Why?
Enterococcus
1
2012
3
0.480
Why?
Risk Factors
7
2020
389
0.470
Why?
Gram-Positive Bacterial Infections
1
2012
8
0.470
Why?
Paramyxoviridae
1
2011
1
0.470
Why?
Streptococcus bovis
1
2011
1
0.460
Why?
Paramyxoviridae Infections
1
2011
10
0.460
Why?
Meningitis, Bacterial
1
2011
6
0.460
Why?
Oligonucleotide Probes
2
2009
8
0.450
Why?
Campylobacter Infections
1
2011
2
0.450
Why?
False Positive Reactions
1
2011
5
0.450
Why?
Adenoviruses, Human
1
2011
1
0.450
Why?
Intensive Care Units, Pediatric
1
2011
7
0.440
Why?
Blood
1
2011
13
0.440
Why?
Catheterization, Peripheral
1
2011
5
0.440
Why?
Meningitis, Viral
2
2022
2
0.430
Why?
Follow-Up Studies
5
2021
307
0.420
Why?
Pediatric Nursing
1
2010
4
0.420
Why?
Infection Control
1
2010
7
0.410
Why?
Genotyping Techniques
2
2020
18
0.410
Why?
Pyelonephritis
4
2004
5
0.390
Why?
Influenza A Virus, H3N2 Subtype
4
2022
6
0.390
Why?
Epidemiological Monitoring
5
2021
6
0.390
Why?
Encephalitis, Viral
1
2009
1
0.390
Why?
Simplexvirus
1
2009
3
0.380
Why?
Haemophilus influenzae
1
2009
4
0.380
Why?
Antifungal Agents
2
2020
12
0.380
Why?
Mycobacterium
2
2010
2
0.380
Why?
Streptococcus pneumoniae
1
2009
16
0.370
Why?
Enterobacteriaceae Infections
2
2018
8
0.360
Why?
Predictive Value of Tests
4
2019
100
0.350
Why?
Adhesins, Bacterial
2
2004
2
0.340
Why?
Reproducibility of Results
3
2012
182
0.330
Why?
beta-Lactamases
3
2018
6
0.320
Why?
Candida albicans
2
2003
4
0.320
Why?
Fucosyltransferases
2
2015
2
0.300
Why?
Algorithms
3
2020
96
0.300
Why?
Cluster Analysis
4
2015
30
0.290
Why?
Immunization Programs
2
2019
6
0.290
Why?
Cross Infection
2
2017
13
0.280
Why?
Collagen Type IV
1
2004
2
0.280
Why?
Escherichia coli Proteins
1
2004
2
0.280
Why?
Fimbriae, Bacterial
4
2001
4
0.280
Why?
Cephalosporin Resistance
3
2018
4
0.270
Why?
Saliva
2
2021
9
0.270
Why?
Longitudinal Studies
2
2020
124
0.250
Why?
Cohort Studies
3
2021
256
0.250
Why?
Acute Disease
2
2020
62
0.250
Why?
DNA Probes
1
2002
3
0.250
Why?
Fluorescent Dyes
1
2002
7
0.250
Why?
Oseltamivir
2
2021
6
0.250
Why?
Viral Fusion Proteins
1
2022
4
0.240
Why?
Seroepidemiologic Studies
2
2019
3
0.240
Why?
Craniocerebral Trauma
1
2022
15
0.240
Why?
Antibodies, Monoclonal
1
2022
24
0.240
Why?
Midwestern United States
2
2013
41
0.240
Why?
Hospitals, Pediatric
3
2020
176
0.230
Why?
Child, Hospitalized
3
2022
27
0.230
Why?
Critical Care
3
2018
12
0.230
Why?
Vaccines
1
2021
13
0.230
Why?
Herpesvirus 1, Cercopithecine
1
2021
1
0.230
Why?
Central Nervous System
1
2021
7
0.230
Why?
Nasal Mucosa
1
2021
8
0.230
Why?
Child Abuse
1
2022
42
0.230
Why?
Immunity, Humoral
1
2021
6
0.230
Why?
Cloud Computing
1
2021
5
0.220
Why?
Risk Assessment
2
2020
133
0.220
Why?
Lung Diseases
1
2021
42
0.220
Why?
Disease Management
2
2018
36
0.220
Why?
Lymphadenitis
2
2013
3
0.220
Why?
Public Health Surveillance
1
2020
4
0.220
Why?
Klebsiella Infections
2
2017
3
0.210
Why?
Ambulatory Care Facilities
1
2021
31
0.210
Why?
ROC Curve
1
2020
18
0.210
Why?
Quebec
1
2020
4
0.210
Why?
Herpesvirus 1, Human
1
2020
2
0.210
Why?
Drug Resistance, Viral
1
2020
3
0.210
Why?
Coronavirus Infections
1
2020
15
0.210
Why?
Guanine Nucleotide Exchange Factors
1
2020
3
0.210
Why?
Pneumonia, Viral
1
2020
16
0.210
Why?
DNA, Bacterial
3
2011
5
0.210
Why?
Mouth
1
2020
3
0.210
Why?
Canada
1
2020
33
0.210
Why?
International Classification of Diseases
1
2020
8
0.210
Why?
Family Health
1
2020
14
0.210
Why?
Gastrointestinal Diseases
1
2021
55
0.210
Why?
Monitoring, Physiologic
1
2020
23
0.210
Why?
Postoperative Care
1
2020
29
0.200
Why?
Europe
1
2020
30
0.200
Why?
Early Diagnosis
1
2020
35
0.200
Why?
Immunoenzyme Techniques
1
2019
12
0.200
Why?
Age Distribution
1
2019
32
0.200
Why?
Prognosis
1
2020
179
0.200
Why?
Gonorrhea
2
2015
4
0.190
Why?
Molecular Epidemiology
3
2017
6
0.190
Why?
History, 21st Century
1
2019
6
0.190
Why?
Chronic Disease
3
2012
104
0.190
Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2019
3
0.190
Why?
Bacterial Typing Techniques
2
2016
4
0.190
Why?
Immunization Schedule
1
2019
7
0.190
Why?
Critical Pathways
1
2018
9
0.190
Why?
Hematologic Diseases
1
2018
4
0.190
Why?
Immunologic Deficiency Syndromes
1
2018
9
0.190
Why?
False Negative Reactions
1
2018
11
0.180
Why?
Intestines
1
2018
27
0.180
Why?
Cytopathogenic Effect, Viral
1
2017
2
0.180
Why?
Sapovirus
1
2017
1
0.170
Why?
Cell Line
1
2017
104
0.170
Why?
Cells, Cultured
1
2017
113
0.170
Why?
Klebsiella pneumoniae
1
2017
2
0.170
Why?
Dose-Response Relationship, Drug
1
2017
99
0.170
Why?
Genetic Predisposition to Disease
2
2015
145
0.170
Why?
Antibiotic Prophylaxis
1
2017
30
0.170
Why?
Practice Guidelines as Topic
1
2017
95
0.170
Why?
Neoplasms
1
2018
90
0.160
Why?
Staphylococcal Skin Infections
1
2016
3
0.160
Why?
Clindamycin
1
2016
3
0.160
Why?
Length of Stay
2
2018
231
0.160
Why?
Recombination, Genetic
1
2015
4
0.150
Why?
Virulence Factors
1
2015
4
0.150
Why?
C-Reactive Protein
1
2015
13
0.150
Why?
Hemoglobins
1
2015
22
0.150
Why?
Chlamydia trachomatis
1
2015
2
0.150
Why?
Trichomonas Vaginitis
1
2015
2
0.150
Why?
Chlamydia Infections
1
2015
3
0.150
Why?
Equipment Failure
1
2015
8
0.140
Why?
Dogs
1
2015
17
0.140
Why?
DNA, Ribosomal
2
2011
3
0.140
Why?
RNA, Ribosomal, 16S
2
2011
7
0.140
Why?
Unnecessary Procedures
1
2015
15
0.140
Why?
Treatment Outcome
5
2018
615
0.140
Why?
Quality Improvement
1
2015
63
0.140
Why?
HeLa Cells
6
2004
21
0.140
Why?
Base Sequence
2
2004
114
0.130
Why?
Age Factors
3
2021
223
0.130
Why?
Molecular Sequence Data
3
2015
120
0.130
Why?
DNA, Fungal
2
2003
5
0.130
Why?
Tertiary Care Centers
1
2013
8
0.130
Why?
Viral Proteins
1
2013
19
0.130
Why?
Incidence
2
2011
130
0.130
Why?
Abscess
1
2013
11
0.130
Why?
Diarrhea
2
2011
16
0.130
Why?
Mice
3
2022
441
0.130
Why?
Anti-Infective Agents
1
2013
18
0.120
Why?
Pneumococcal Infections
2
2011
16
0.120
Why?
Vaccines, Attenuated
3
2019
7
0.120
Why?
Costs and Cost Analysis
1
2012
7
0.120
Why?
Epitopes
2
2022
19
0.120
Why?
Enterotoxins
1
2011
2
0.110
Why?
Middle Ear Ventilation
1
2011
1
0.110
Why?
Exudates and Transudates
1
2011
2
0.110
Why?
Operon
3
2001
4
0.110
Why?
Communicable Diseases
1
2011
6
0.110
Why?
Campylobacter
1
2011
2
0.110
Why?
Restriction Mapping
1
2011
14
0.110
Why?
Serotyping
1
2011
6
0.110
Why?
Epidemiologic Methods
1
2011
2
0.110
Why?
Policy Making
1
2011
3
0.110
Why?
Immunocompromised Host
2
2020
9
0.110
Why?
Cost of Illness
2
2020
15
0.100
Why?
Quality of Health Care
1
2010
18
0.100
Why?
Linear Models
1
2010
54
0.100
Why?
Postoperative Complications
1
2011
176
0.100
Why?
Cross-Sectional Studies
3
2019
278
0.100
Why?
Disease Models, Animal
3
2005
80
0.100
Why?
Databases, Factual
1
2010
106
0.100
Why?
Parents
2
2021
126
0.100
Why?
Moraxellaceae Infections
1
2009
1
0.100
Why?
Haemophilus Infections
1
2009
5
0.100
Why?
Bacterial Proteins
3
2017
8
0.090
Why?
Chromatography, High Pressure Liquid
2
2010
43
0.090
Why?
Mycobacterium avium-intracellulare Infection
1
2008
2
0.090
Why?
Mutation
3
2019
202
0.090
Why?
Biomarkers
2
2021
117
0.090
Why?
DNA, Ribosomal Spacer
2
2010
3
0.090
Why?
Temperature
2
2010
11
0.090
Why?
Adenoviridae
1
2007
4
0.090
Why?
Virulence
2
2004
6
0.080
Why?
Mycobacterium Infections
1
2006
1
0.080
Why?
Mice, Inbred C3H
2
2004
10
0.080
Why?
Anemia, Sickle Cell
1
2006
17
0.080
Why?
Illinois
2
2015
4
0.070
Why?
Enzyme-Linked Immunosorbent Assay
2
2015
24
0.070
Why?
Pregnancy Complications, Infectious
2
2001
29
0.070
Why?
Chromatography, Gas
1
2004
1
0.070
Why?
Fatty Acids
1
2004
4
0.070
Why?
Culture Media
1
2003
1
0.070
Why?
Candida glabrata
1
2003
1
0.070
Why?
Mycology
1
2003
2
0.070
Why?
Gene Amplification
1
2003
6
0.070
Why?
CHO Cells
2
2002
4
0.070
Why?
Cricetinae
2
2002
7
0.070
Why?
DNA Primers
1
2003
41
0.070
Why?
Kidney
1
2004
89
0.070
Why?
Phenotype
1
2004
217
0.060
Why?
Mycological Typing Techniques
1
2002
3
0.060
Why?
Candidiasis
1
2002
5
0.060
Why?
Vaccines, Synthetic
1
2022
9
0.060
Why?
Complement System Proteins
1
2002
5
0.060
Why?
Macaca nemestrina
1
2002
1
0.060
Why?
Trypanosoma cruzi
1
2002
2
0.060
Why?
Chagas Disease
1
2002
2
0.060
Why?
Hematoma, Subdural
1
2022
4
0.060
Why?
Microbiological Techniques
2
2015
5
0.060
Why?
Hospitals
1
2022
36
0.060
Why?
Immunity, Cellular
1
2021
9
0.060
Why?
Viral Load
1
2021
22
0.060
Why?
Epitope Mapping
1
2021
7
0.060
Why?
Antibody Specificity
1
2021
9
0.060
Why?
Cross Reactions
1
2021
7
0.060
Why?
Immunity, Innate
1
2021
17
0.060
Why?
Receptors, Cell Surface
1
2001
15
0.060
Why?
Host-Pathogen Interactions
1
2021
8
0.060
Why?
T-Lymphocytes
1
2021
35
0.060
Why?
Transcriptome
1
2021
34
0.060
Why?
Viruses
1
2021
2
0.060
Why?
Phosphoproteins
1
2021
17
0.060
Why?
Vaccine Potency
1
2021
7
0.060
Why?
Microtubules
2
1999
6
0.060
Why?
Bacteria
1
2021
9
0.060
Why?
Immunization
1
2021
21
0.060
Why?
Pregnancy
4
2005
252
0.050
Why?
Immunoglobulin G
1
2021
34
0.050
Why?
Comorbidity
1
2021
68
0.050
Why?
Neck
2
2013
4
0.050
Why?
Dialysis Solutions
1
2021
19
0.050
Why?
Catheters, Indwelling
1
2021
27
0.050
Why?
Self Care
1
2021
23
0.050
Why?
Catheterization
1
2021
25
0.050
Why?
RNA, Messenger
1
2021
178
0.050
Why?
Skin
1
2020
14
0.050
Why?
Family Characteristics
1
2020
8
0.050
Why?
Vacuoles
1
2000
1
0.050
Why?
Glycosylphosphatidylinositols
1
2000
1
0.050
Why?
Interviews as Topic
1
2020
34
0.050
Why?
RNA, Ribosomal, 23S
1
2019
1
0.050
Why?
Liver
1
2021
159
0.050
Why?
Cytoskeleton
1
1999
3
0.050
Why?
Infectious Disease Transmission, Vertical
1
1999
28
0.050
Why?
Medically Uninsured
1
2019
5
0.050
Why?
Premature Birth
1
2019
5
0.050
Why?
Australia
1
2019
8
0.050
Why?
Netherlands
1
2019
5
0.050
Why?
Polymorphism, Single Nucleotide
1
2020
205
0.050
Why?
Regression Analysis
1
2018
59
0.050
Why?
Metabolic Diseases
1
2018
13
0.050
Why?
Practice Patterns, Nurses'
1
2017
5
0.040
Why?
Bacterial Outer Membrane Proteins
1
2017
1
0.040
Why?
beta-Lactam Resistance
1
2017
1
0.040
Why?
Fimbriae Proteins
1
2017
1
0.040
Why?
Penicillin-Binding Proteins
1
2016
2
0.040
Why?
Pharmacy Service, Hospital
1
2016
8
0.040
Why?
Practice Patterns, Physicians'
1
2017
79
0.040
Why?
Sequence Homology
1
2015
2
0.040
Why?
Evolution, Molecular
1
2015
3
0.040
Why?
Genome, Viral
1
2015
4
0.040
Why?
China
1
2015
9
0.040
Why?
Dyspnea
1
2015
5
0.040
Why?
Colorado
1
2015
9
0.040
Why?
Respiratory Sounds
1
2015
7
0.040
Why?
Cough
1
2015
7
0.040
Why?
Respiration, Artificial
1
2015
31
0.040
Why?
Emergency Medical Services
1
2015
13
0.040
Why?
Primary Health Care
1
2015
42
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2015
83
0.040
Why?
Clinical Laboratory Services
1
2015
2
0.040
Why?
Economics, Hospital
1
2015
3
0.040
Why?
Sexually Transmitted Diseases
1
2015
8
0.040
Why?
Cost Savings
1
2015
10
0.040
Why?
Gene Frequency
1
2015
75
0.040
Why?
Program Evaluation
1
2015
48
0.040
Why?
Sexual Behavior
1
2015
35
0.030
Why?
Asthma
1
2015
136
0.030
Why?
Drainage
1
2013
38
0.030
Why?
Rats, Sprague-Dawley
2
2005
97
0.030
Why?
Ambulatory Care
1
2013
40
0.030
Why?
Rats
2
2005
208
0.030
Why?
Diagnostic Test Approval
1
2011
1
0.030
Why?
Tympanic Membrane
1
2011
1
0.030
Why?
Prosthesis Failure
1
2011
2
0.030
Why?
Administration, Topical
1
2011
6
0.030
Why?
United States Food and Drug Administration
1
2011
7
0.030
Why?
Otitis Media with Effusion
1
2011
2
0.030
Why?
Administration, Oral
1
2011
65
0.030
Why?
Recurrence
1
2011
104
0.030
Why?
Cell Wall
1
2010
1
0.030
Why?
Mycolic Acids
1
2010
1
0.030
Why?
Pigments, Biological
1
2010
1
0.030
Why?
Chaperonin 60
1
2010
1
0.030
Why?
Enzyme Stability
1
2010
3
0.030
Why?
DNA-Directed RNA Polymerases
1
2010
2
0.030
Why?
Africa
1
2010
2
0.030
Why?
Enzymes
1
2010
5
0.030
Why?
Hot Temperature
1
2010
4
0.030
Why?
Binding Sites
2
2002
50
0.030
Why?
Bacterial Adhesion
2
1999
2
0.020
Why?
Face
1
2008
2
0.020
Why?
Cefoxitin
1
2006
1
0.020
Why?
Doxycycline
1
2006
1
0.020
Why?
Hydroxyurea
1
2006
1
0.020
Why?
Linezolid
1
2006
2
0.020
Why?
Ciprofloxacin
1
2006
3
0.020
Why?
Acetamides
1
2006
2
0.020
Why?
Oxazolidinones
1
2006
2
0.020
Why?
Clarithromycin
1
2006
3
0.020
Why?
Mycobacterium fortuitum
1
2006
2
0.020
Why?
Amikacin
1
2006
3
0.020
Why?
Drug Therapy, Combination
1
2006
43
0.020
Why?
Uterine Diseases
1
2005
1
0.020
Why?
Gene Expression Regulation, Bacterial
1
2005
1
0.020
Why?
Structure-Activity Relationship
1
2002
16
0.020
Why?
Models, Molecular
1
2002
18
0.020
Why?
Protein Structure, Tertiary
1
2002
17
0.020
Why?
Mutagenesis, Site-Directed
1
2002
20
0.020
Why?
DNA, Kinetoplast
1
2002
1
0.020
Why?
Antibodies
1
2002
15
0.020
Why?
Antibodies, Protozoan
1
2002
3
0.020
Why?
Repetitive Sequences, Nucleic Acid
1
2002
9
0.020
Why?
Protein Binding
1
2002
49
0.020
Why?
B-Lymphocytes
1
2002
18
0.020
Why?
Gene Expression
1
2002
74
0.010
Why?
Blood Group Antigens
1
2001
2
0.010
Why?
Oligonucleotides
1
2001
6
0.010
Why?
Intestinal Diseases
1
2001
5
0.010
Why?
Hemagglutinins
1
2001
1
0.010
Why?
Terminology as Topic
1
2001
14
0.010
Why?
Neisseria gonorrhoeae
1
1999
1
0.010
Why?
Complement C1q
1
1999
3
0.010
Why?
Cattle
1
1999
26
0.010
Why?
Actins
1
1999
5
0.010
Why?
Recombinant Proteins
1
1999
67
0.010
Why?
Cytochalasin D
1
1997
1
0.010
Why?
Nocodazole
1
1997
1
0.010
Why?
Microscopy, Electron
1
1997
7
0.010
Why?
Immunohistochemistry
1
1997
68
0.010
Why?
Selvarangan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Physical Neighbors Expand Description
_